Document 0822 DOCN M9590822 TI Association between maternal antibodies to the external envelope glycoprotein and vertical transmission of human T-lymphotropic virus type I. Maternal anti-env antibodies correlate with protection in non-breast-fed children. DT 9509 AU Hino S; Katamine S; Miyamoto T; Doi H; Tsuji Y; Yamabe T; Kaplan JE; Rudolph DL; Lal RB; Department of Virology, Faculty of Medicine, Tottori University,; Yonago, Japan. SO J Clin Invest. 1995 Jun;95(6):2920-5. Unique Identifier : AIDSLINE MED/95286861 AB Vertical transmission of human T-lymphotropic virus type I (HTLV-I) depends primarily on breast-feeding; substitution of bottle-feeding has reduced the transmission rate from 20% in breast-fed children to 3% among bottle-fed. To determine the correlates of transmission for long breast-feeding (> or = 6 mo), short breast-feeding (< 6 mo), and bottle-feeding mothers, the antibody titers of transmitter (T) mothers and non-transmitter (nT) mothers were analyzed by using synthetic and recombinant epitopes representing the immunodominant epitopes of gag (Gag1a, r24), env (Env1/5, MTA1, RE3), and tax (Tax8/22-24) proteins. Seroreactivity to gag and tax epitopes was not significantly different except for anti-r24 antibody titer, which was significantly higher among T-mothers (geometric mean 134) when compared with nT-mothers (62) in the long-feeding group (P < 0.001). Profiles of antibody titers against env epitopes were different. Within the long-feeding group, Env1/5, MTA1, and RE3 titers were significantly higher among T-mothers (258, 1,476, and 738, respectively) when compared with nT-mothers (106, 279, and 320, respectively) (P < 0.01 for all three epitopes). In contrast, within the bottle-feeding group, antibody titers to Env1/5 (269) and RE3 (418) among nT-mothers were significantly higher than those among T-mothers (80 and 113, respectively) (P < 0.01). These data confirm that high-titered anti-HTLV-I antibodies in the long-feeding group correlate with milk-borne transmission of HTLV-I and, more importantly, imply that maternal anti-env antibodies may reduce the risk of non-milkborne infection. DE Amino Acid Sequence Breast Feeding Female Gene Products, env/*IMMUNOLOGY Gene Products, gag/IMMUNOLOGY Human HTLV-BLV Antibodies/*IMMUNOLOGY HTLV-BLV Antigens/IMMUNOLOGY HTLV-I/*IMMUNOLOGY HTLV-I Infections/*TRANSMISSION Membrane Glycoproteins/IMMUNOLOGY Milk, Human/IMMUNOLOGY Molecular Sequence Data Peptides/CHEMISTRY/IMMUNOLOGY Pregnancy Support, Non-U.S. Gov't Support, U.S. Gov't, Non-P.H.S. Time Factors JOURNAL ARTICLE SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).